Isuprel, Injektionslösung / Konzentrat zur Herstellung einer Infusionslösung

7680564570022 CH-56457 Injektionslösung
Isuprel, Injektionslösung / Konzentrat zur Herstellung einer Infusionslösung
Isuprel, Injektionslösung / Konzentrat zur Herstellung einer Infusionslösung
Isuprel, Injektionslösung / Konzentrat zur Herstellung einer Infusionslösung
1 / 3
google

Article details

Package size
5 x 1ml
Selling units
5
Measure
Ampulle(n)
Galenic form
Injektionslösung
Galenic group
Injektion/Infusion

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Summary of Product Characteristics
Allemand
25/11/2020
Summary of Product Characteristics
Français
25/11/2020
Summary of Product Characteristics
Italien
25/11/2020

Detailed composition

Substance Quantity Type Category
(N/A)
0.2 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HBESI

Authorization holder

Ospedalia AG

6331 Hünenberg

Authorization information

Swissmedic authorization number
56457
Drug name
Isuprel, Injektionslösung / Konzentrat zur Herstellung einer Infusionslösung
Galenic form
LSIN
ATC Code
C01CA02
Authorization status
Z
Dispensing category
B
First authorization
28/10/2010
Authorization expiration date
31/12/9999
IT Number
02.05.2.
Domain
Human medicine
Field of application
Sympathomimetikum

Package details

Description (FR)
ISUPREL conc perf 0.2 mg/ml 5 amp 1 ml
Description (DE)
ISUPREL Inf Konz 0.2 mg/ml 5 Amp 1 ml
Market launch
28/10/2010
Narcotic (BTM)
No

Other package sizes (1)

None
None None
GTIN: None
Not in V1